Anthracyclines

calreticulin ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35478050 Photodynamic therapy using mannose-conjugated chlorin e6 increases cell surface calreticulin in cancer cells and promotes macrophage phagocytosis. 2022 Apr 28 2
2 34638242 Current and Future Therapies for Immunogenic Cell Death and Related Molecules to Potentially Cure Primary Breast Cancer. 2021 Sep 23 1
3 31413915 A fluorescent biosensor-based platform for the discovery of immunogenic cancer cell death inducers. 2019 2
4 32923172 Contribution of annexin A1 to anticancer immunosurveillance. 2019 1
5 25050214 Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set. 2014 1
6 22905553 Synthesis of mercaptosuccinic acid/MercaptoPolyhedral oligomeric silsesquioxane coated cadmium telluride quantum dots in cell labeling applications. 2012 Jun 1
7 21602432 Human tumor cells killed by anthracyclines induce a tumor-specific immune response. 2011 Jul 15 1
8 20699648 Lysyl tRNA synthetase is required for the translocation of calreticulin to the cell surface in immunogenic death. 2010 Aug 1 1
9 20958319 Surface-exposed calreticulin in the interaction between dying cells and phagocytes. 2010 Oct 1
10 21368877 Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia. 2010 Dec 2 3
11 18353726 Immunogenicity of anthracyclines: moving towards more personalized medicine. 2008 Apr 1
12 18464797 The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. 2008 Sep 5
13 17804698 Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic. 2007 Sep 1 1
14 17804868 Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells. 2007 Mar-Apr 1
15 17979837 Ecto-calreticulin in immunogenic chemotherapy. 2007 Dec 2